Parameter | 2006–2010 (N = 92) | 2011–2015 (N = 101) | p-value |
---|---|---|---|
Age (years), SD | 53.2 ± 13.07 | 55.4 ± 9.48 | 0.192 |
Marital status | Â | Â | 0.136 |
 Married | 74 (80.4) | 89 (88.1) |  |
 Non-married (single) | 11 (14.0) | 4 (4.0) |  |
 Widowed or divorced | 7 (7.6) | 8 (7.9) |  |
Parity | Â | Â | 0.180 |
 0 | 17 (18.5) | 10 (9.9) |  |
 1 | 13 (14.1) | 20 (19.8) |  |
  ≥ 2 | 62 (67.4) | 71 (70.3) |  |
Primary cancer | Â | Â | 0.350 |
 Ovarian cancer | 57 (62.0) | 53 (52.5) |  |
 Cervical cancer | 16 (17.4) | 23 (22.8) |  |
 Uterine cancer | 15 (16.3) | 23 (22.8) |  |
 Vagina or vulvar cancer | 4 (4.3) | 2 (2.0) |  |
FIGO stage | Â | Â | 0.447 |
 I | 10 (10.9) | 16 (15.8) |  |
 II | 16 (17.4) | 2 (14.5) |  |
 III | 47 (51.1) | 47 (46.5) |  |
 IV | 19 (20.7) | 26 (25.7) |  |
ECOG PS score at the last admission | Â | Â | 0.248 |
 0 | 41 (44.6) | 31 (30.7) |  |
 1 | 24 (26.1) | 30 (29.7) |  |
 2 | 12 (13.0) | 23 (22.8) |  |
 3 | 10 (10.9) | 10 (9.9) |  |
 4 | 5 (5.4) | 7 (6.9) |  |
Reason for last admission | Â | Â | 0.775 |
 Procedure or palliative treatment | 16 (17.4) | 12 (11.9) |  |
 Gastrointestinal symptoms | 25 (27.2) | 27 (26.7) |  |
 Cardiovascular or pulmonary symptoms | 17 (18.5) | 22 (21.8) |  |
 Infectious state | 11 (12.0) | 20 (19.8) |  |
 Uncontrolled pain | 6 (6.5) | 5 (5.0) |  |
 Hematologic instability | 7 (7.6) | 5 (5.0) |  |
 Neurologic symptoms | 3 (3.3) | 4 (4.0) |  |
 Others | 7 (7.6) | 6 (5.9) |  |
ICU admission in the last month | 11 (12.0) | 12 (11.9) | 0.987 |
Imaging examination conducted in the last month | Â | Â | 0.011 |
 No examination | 35 (38.0) | 21 (20.8) |  |
 Examination (CT, MRI, PET-CT) | 57 (62.0) | 80 (79.2) |  |
Type of treatment administered during the last 6 mo | Â | Â | 0.004 |
 Chemotherapy alone | 82 (89.1) | 73 (72.3) |  |
 Chemotherapy with radiation or surgery | 10 (10.9) | 28 (27.7) |  |
Type of chemotherapy-agent administered during the last 6 mo | Â | Â | 0.199 |
 IV only | 87 (94.6) | 90 (89.1) |  |
 IV with PO | 5 (5.4) | 11 (10.9) |  |
Number of total palliative chemotherapy sessions | 3.08 | 3.24 | 0.587 |
Frequency of admission during the last 6 mo | 5.12 | 6.06 | 0.003 |
Frequency of chemotherapy during the last 6 mo | 3.84 | 4.93 | <  0.001 |
Invasive procedure during the last 3 mo | 38 (41.3) | 57 (56.4) | 0.044 |
Duration from last admission to death (d) | 27.0 | 24.3 | 0.535 |
Duration from last chemotherapy to death (d) | 58.1 | 47.0 | 0.067 |
Date of last chemotherapy before death | Â | Â | 0.486 |
 Between the last 3 mo and 6 mo | 20 (21.7) | 18 (17.8) |  |
 Between the last 1 mo and 3 mo | 47 (51.1) | 45 (44.6) |  |
 Between the last 1 mo and 2 wk | 12 (13.0) | 19 (18.8) |  |
 Within the last 2wk | 12 (13.0) | 20 (19.8) |  |